The clinical and economic implications of specimen provenance complications in diagnostic prostate biopsies

Journal of Urology

Volumn 193, Issue 4, 2015, Pages 1170-1177

  Wojno, Kirk ^a   Hornberger, John ^b,c   Schellhammer, Paul ^d,e   Dai, Minghan ^c   Morgan, Travis ^e  

^a Pathology   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Cedar Asocits LLC   (United States)

^d Urology of Virginia   (United States)

^e Strand Diagnostics   (United States)

Author keywords

biopsy; costs and cost analysis; diagnostic errors; prostate; specimen handling

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ERROR; HEALTH CARE COST; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SPECIMEN PROVENANCE COMPLICATION; SYSTEMATIC REVIEW (TOPIC); AGED; BIOPSY; ECONOMICS; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY; DIAGNOSTIC ERRORS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; SPECIMEN HANDLING; UNITED STATES;

EID: 84926418737     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.11.019     Document Type: Article

References (29)

1. E.J. Suba, J.D. Pfeifer, and S.S. Raab Patient identification error among prostate needle core biopsy specimens - are we ready for a DNA time-out? J Urol 178 2007 1245
2. J.D. Pfeifer, and J. Liu Rate of occult specimen provenance complications in routine clinical practice Am J Clin Pathol 139 2013 93
3. M. Marberger, J.D. McConnell, and I. Fowler Biopsy misidentification identified by DNA profiling in a large multicenter trial J Clin Oncol 29 2011 1744
4. T. Shiroiwa, Y.K. Sung, and T. Fukuda International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 19 2010 422
5. S. Ramsey, R. Willke, and A. Briggs Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report Value Health 8 2005 521
6. National Cancer Institute: SEER Stat Fact Sheet: Prostate Cancer. Available at http://seer.cancer.gov/statfacts/html/prost.html. Accessed January 16, 2014.
7. D.A. Kapoor, D.G. Bostwick, and S.E. Mendrinos Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011 Rev Urol 15 2013 137
8. H.G. Welch, E.S. Fisher, and D.J. Gottlieb Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era J Natl Cancer Inst 99 2007 1395
9. Integrated Practices Comprehensive Care: Latest News: LUGPA Announces New President. Available at http://lugpa.org/featured/lugpa-annouces-new-president/. Accessed March 5, 2014.
10. Medscape Medical News: Urologist Shortage Projected in US. Available at http://www.medscape.com/viewarticle/803670. Accessed March 5, 2014.
11. G.N. Gephardt, and R.J. Zarbo Extraneous tissue in surgical pathology: a College of American Pathologists Q-Probes study of 275 laboratories Arch Pathol Lab Med 120 1996 1009
12. National Comprehensive Cancer Network: Prostate Cancer Early Detection, Version 2.2012. Available at www.nccn.org. Accessed January 24, 2014.
13. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203
14. Centers for Disease Control and Prevention: National Vital Statistics Report 2014. Available at http://www.cdc.gov/nchs/data/nvsr/nvsr62/nvsr62-07.pdf. Accessed January 9, 2014.
15. D.J. Perlroth, J. Bhattacharya, and D.P. Goldman An economic analysis of conservative management versus active treatment for men with localized prostate cancer J Natl Cancer Inst Monogr 2012 2012 250
16. C.F. Snyder, K.D. Frick, and A.L. Blackford How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer? Cancer 116 2010 5391
17. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117
18. P.L. Nguyen, X. Gu, and S.R. Lipsitz Cost implications of the rapid adoption of newer technologies for treating prostate cancer J Clin Oncol 29 2011 1517
19. M.R. Cooperberg, N.R. Ramakrishna, and S.B. Duff Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis BJU Int 111 2013 437
20. J.D. Pfeifer, M.N. Singleton, and M.H. Gregory Development of a decision-analytic model for the application of STR-based provenance testing of transrectal prostate biopsy specimens Value Health 15 2012 860
21. Journal of Oncology Practice: The State of Cancer Care in America, 2014: A Report by the American Society of Clinical Oncology. Available at http://www.asco.org/practice-research/cancer-care-america. Accessed March 28, 2014.
22. Bureau of Labor Statistics: Consumer Price Index - All Urban Consumers. Available at http://www.bls.gov/cpi/. Accessed February 27, 2014.
23. W. Dale, A. Basu, and A. Elstein Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories Med Decis Making 28 2008 102
24. S.T. Stewart, L. Lenert, and V. Bhatnagar Utilities for prostate cancer health states in men aged 60 and older Med Care 43 2005 347
25. J.H. Hayes, D.A. Ollendorf, and S.D. Pearson Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis JAMA 304 2010 2373
26. I. Thompson, J.B. Thrasher, and G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106
27. P.F. Stahel, A.L. Sabel, and M.S. Victoroff Wrong-site and wrong-patient procedures in the universal protocol era: analysis of a prospective database of physician self-reported occurrences Arch Surg 145 2010 978
28. M. Colaco, J. Sandberg, and G. Badlani Influencing factors leading to malpractice litigation in radical prostatectomy J Urol 191 2014 1770
29. D. Golann Dropped medical malpractice claims: their surprising frequency, apparent causes, and potential remedies Health Aff (Millwood) 30 2011 1343